AstraZeneca (AZN) to Report Q4 Earnings: Here's What to Expect

AstraZeneca (AZN) will report fourth-quarter and full-year 2023 results on Feb 8, before market open. In the last reported quarter, the company beat earnings expectations by 8.75%.Factors to NoteSales of AstraZeneca’s key medicines, mainly cancer drugs — Lynparza, Tagrisso, and Imfinzi — and diabetes medicine Farxiga, are expected to have driven the company’s top line in the fourth quarter, backed by strong demand trends.Approvals for new indications have been boosting sales growth of some key drugs like Im ...